• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病与心血管疾病风险。

Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.

机构信息

Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

出版信息

Eur J Epidemiol. 2010 Apr;25(4):253-60. doi: 10.1007/s10654-010-9435-7. Epub 2010 Feb 27.

DOI:10.1007/s10654-010-9435-7
PMID:20191376
Abstract

Previous large epidemiological studies reporting on the association between chronic obstructive pulmonary disease (COPD) and cardiovascular diseases mainly focussed on prevalent diseases rather than on the incidence of newly diagnosed cardiovascular outcomes. We used the UK-based General Practice Research Database (GPRD) to assess the prevalence and incidence of cardiovascular diseases in COPD patients aged 40-79 between 1995 and 2005, and we randomly matched COPD-free comparison patients to COPD patients. In nested-case control analyses, we compared the risks of developing an incident diagnosis of cardiac arrhythmias, venous thromboembolism, myocardial infarction, or stroke between patients with and without COPD, stratifying the analyses by COPD-severity, using COPD-treatment as proxy for disease severity. We identified 35,772 patients with COPD and the same number of COPD-free patients. Most cardiovascular diseases were more prevalent among COPD patients than among the comparison group of COPD-free patients. The relative risk estimates of developing an incident diagnosis of cardiac arrhythmia (OR 1.19, 95% CI 0.98-1.43), deep vein thrombosis (OR 1.35, 95% CI 0.97-1.89), pulmonary embolism (OR 2.51, 95% CI 1.62-3.87), myocardial infarction (OR 1.40, 95% CI 1.13-1.73), or stroke (OR 1.13, 95% CI 0.92-1.38), tended to be increased for patients with COPD as compared to COPD-free controls. The findings of this large observational study provide further evidence that patients with COPD are at increased risk for most cardiovascular diseases.

摘要

先前的大型流行病学研究报告表明,慢性阻塞性肺疾病(COPD)与心血管疾病之间存在关联,主要集中在已确诊的疾病上,而非新诊断的心血管疾病的发病率上。我们利用英国的全科医生研究数据库(GPRD)评估了 1995 年至 2005 年间年龄在 40-79 岁的 COPD 患者中心血管疾病的患病率和发病率,并随机匹配了无 COPD 的对照患者。在巢式病例对照分析中,我们比较了有和无 COPD 的患者发生心律失常、静脉血栓栓塞、心肌梗死或中风等新发诊断的风险,通过 COPD 严重程度对分析进行分层,使用 COPD 治疗作为疾病严重程度的替代指标。我们确定了 35772 例 COPD 患者和相同数量的无 COPD 患者。大多数心血管疾病在 COPD 患者中比在无 COPD 的对照组中更为常见。发生心律失常(OR 1.19,95%CI 0.98-1.43)、深静脉血栓形成(OR 1.35,95%CI 0.97-1.89)、肺栓塞(OR 2.51,95%CI 1.62-3.87)、心肌梗死(OR 1.40,95%CI 1.13-1.73)或中风(OR 1.13,95%CI 0.92-1.38)的风险比,COPD 患者相对于无 COPD 对照者往往更高。这项大型观察性研究的结果进一步证明,COPD 患者发生大多数心血管疾病的风险增加。

相似文献

1
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases.慢性阻塞性肺疾病与心血管疾病风险。
Eur J Epidemiol. 2010 Apr;25(4):253-60. doi: 10.1007/s10654-010-9435-7. Epub 2010 Feb 27.
2
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.加拿大萨斯喀彻温省慢性阻塞性肺疾病患者的心血管疾病,慢性阻塞性肺疾病患者的心血管疾病
Ann Epidemiol. 2006 Jan;16(1):63-70. doi: 10.1016/j.annepidem.2005.04.008. Epub 2005 Jul 21.
3
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.在初级保健中使用数据的综合分析:COPD 患者主要合并症的患病率与心肌梗死和中风的发生率。
Thorax. 2010 Nov;65(11):956-62. doi: 10.1136/thx.2009.128082. Epub 2010 Sep 25.
4
Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).加那利群岛慢性阻塞性肺疾病患者的心血管合并症(CCECAN研究)。
Clin Investig Arterioscler. 2017 Jul-Aug;29(4):149-156. doi: 10.1016/j.arteri.2017.01.003. Epub 2017 Apr 5.
5
Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病患者心血管合并症的风险:系统评价和荟萃分析。
Lancet Respir Med. 2015 Aug;3(8):631-9. doi: 10.1016/S2213-2600(15)00241-6. Epub 2015 Jul 22.
6
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.英国慢性阻塞性肺疾病的流行病学、严重程度及治疗(依据2013年慢性阻塞性肺疾病全球倡议)
Int J Chron Obstruct Pulmon Dis. 2015 May 13;10:925-37. doi: 10.2147/COPD.S82064. eCollection 2015.
7
Temporal Trends in the Incidence of Heart Failure among Patients with Chronic Obstructive Pulmonary Disease and Its Association with Mortality.慢性阻塞性肺疾病患者心力衰竭发病率的时间趋势及其与死亡率的关联
Ann Am Thorac Soc. 2020 Aug;17(8):939-948. doi: 10.1513/AnnalsATS.201911-820OC.
8
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.慢性阻塞性肺疾病与心血管疾病住院及死亡事件:凯撒医疗保健计划
Chest. 2005 Oct;128(4):2068-75. doi: 10.1378/chest.128.4.2068.
9
Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study.慢性阻塞性肺疾病患者的心力衰竭、心肌梗死、肺癌和死亡:一项英国初级保健研究。
Respir Med. 2010 Nov;104(11):1691-9. doi: 10.1016/j.rmed.2010.04.018. Epub 2010 May 18.
10
Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.慢性阻塞性肺疾病患者吸入长效支气管扩张剂与心血管风险的相关性:一项巢式病例对照研究。
JAMA Intern Med. 2018 Feb 1;178(2):229-238. doi: 10.1001/jamainternmed.2017.7720.

引用本文的文献

1
Association Between ABO Blood Type and Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis.ABO血型与肺栓塞风险之间的关联:一项系统评价与荟萃分析
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251364267. doi: 10.1177/10760296251364267. Epub 2025 Jul 28.
2
Impacts of COPD exacerbation history on mortality and severe cardiovascular events among patients with COPD in China: a retrospective cohort study.慢性阻塞性肺疾病(COPD)加重病史对中国COPD患者死亡率和严重心血管事件的影响:一项回顾性队列研究
Respir Res. 2025 Jul 23;26(1):252. doi: 10.1186/s12931-025-03316-4.
3
Comprehensive Risk Score for Prophylaxis Guidance of Postoperative Pulmonary Embolism in Laryngopharyngeal Cancer Patients: A Multicenter Cohort Study.

本文引用的文献

1
Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease.慢性阻塞性肺疾病合并肺癌和/或心血管疾病。
Proc Am Thorac Soc. 2008 Dec 1;5(8):842-7. doi: 10.1513/pats.200807-075TH.
2
COPD as a systemic disease.慢性阻塞性肺疾病作为一种全身性疾病。
COPD. 2008 Apr;5(2):133-8. doi: 10.1080/15412550801941349.
3
Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort.中年人群队列中肺功能损害与心血管事件发生率或复发率之间的关系。
喉咽癌患者术后肺栓塞预防指导的综合风险评分:一项多中心队列研究
Ann Surg Oncol. 2025 Mar 23. doi: 10.1245/s10434-025-17198-9.
4
Diagnosis and management of comorbid disease in COPD.慢性阻塞性肺疾病(COPD)合并症的诊断与管理
Breathe (Sheff). 2025 Feb 25;21(1):240099. doi: 10.1183/20734735.0099-2024. eCollection 2025 Jan.
5
Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.慢性阻塞性肺疾病合并冠心病的研究现状与方向:2005年至2024年的文献计量分析
Int J Chron Obstruct Pulmon Dis. 2025 Jan 7;20:23-41. doi: 10.2147/COPD.S495326. eCollection 2025.
6
Prevalence and Impact of Chronic Obstructive Pulmonary Disease in Ischemic Heart Disease: A Systematic Review and Meta-Analysis of 18 Million Patients.慢性阻塞性肺疾病在缺血性心脏病患者中的患病率和影响:一项纳入 1800 万患者的系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 22;19:2333-2345. doi: 10.2147/COPD.S474223. eCollection 2024.
7
Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review.慢性阻塞性肺疾病患者的心血管风险:一项系统评价
J Clin Med. 2024 Aug 31;13(17):5173. doi: 10.3390/jcm13175173.
8
Venous and Arterial Thromboembolism in Lung Cancer Patients: A Retrospective Analysis.肺癌患者的静脉和动脉血栓栓塞:一项回顾性分析。
J Clin Med. 2024 Jun 27;13(13):3773. doi: 10.3390/jcm13133773.
9
Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.慢性阻塞性肺疾病患者发生缺血性心脏病的风险:一项全国性队列研究。
J Korean Med Sci. 2023 Oct 30;38(42):e344. doi: 10.3346/jkms.2023.38.e344.
10
Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study.COPD 急性加重期患者静脉血栓栓塞症的患病率、危险因素及临床特征:一项前瞻性多中心研究。
Int J Chron Obstruct Pulmon Dis. 2023 May 18;18:907-917. doi: 10.2147/COPD.S410954. eCollection 2023.
Thorax. 2008 Jul;63(7):599-605. doi: 10.1136/thx.2007.088112. Epub 2008 Feb 1.
4
The tobacco epidemic in the United States.美国的烟草流行情况。
Am J Prev Med. 2007 Dec;33(6 Suppl):S318-26. doi: 10.1016/j.amepre.2007.09.008.
5
Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes.慢性阻塞性肺疾病对心肌梗死后结局的影响。
Am J Cardiol. 2007 Mar 1;99(5):636-41. doi: 10.1016/j.amjcard.2006.09.112. Epub 2007 Jan 9.
6
Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities study.肺功能与缺血性中风发病率:社区动脉粥样硬化风险研究
Chest. 2006 Dec;130(6):1642-9. doi: 10.1378/chest.130.6.1642.
7
Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991-1999.1991 - 1999年退伍军人管理局医疗系统中慢性阻塞性肺疾病患者的趋势及心血管合并症
COPD. 2005 Mar;2(1):35-41. doi: 10.1081/copd-200050671.
8
Antimicrobial-associated QT interval prolongation: pointes of interest.抗菌药物相关的QT间期延长:关注点
Clin Infect Dis. 2006 Dec 15;43(12):1603-11. doi: 10.1086/508873. Epub 2006 Nov 8.
9
Chronic obstructive pulmonary disease severity and cardiovascular outcomes.慢性阻塞性肺疾病的严重程度与心血管结局
Eur J Epidemiol. 2006;21(11):803-13. doi: 10.1007/s10654-006-9066-1. Epub 2006 Nov 15.
10
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.美国心脏病学会/美国心脏协会/欧洲心脏病学会2006年心房颤动患者管理指南:全文:美国心脏病学会/美国心脏协会实践指南工作组和欧洲心脏病学会实践指南委员会(修订2001年心房颤动患者管理指南写作委员会)与欧洲心律协会和心律学会合作制定。
Europace. 2006 Sep;8(9):651-745. doi: 10.1093/europace/eul097.